459 related articles for article (PubMed ID: 17504839)
1. Propylthiouracil versus methimazole in treatment of Graves' disease during pregnancy.
Chattaway JM; Klepser TB
Ann Pharmacother; 2007 Jun; 41(6):1018-22. PubMed ID: 17504839
[TBL] [Abstract][Full Text] [Related]
2. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcome of Graves' disease in Thai children.
Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
[TBL] [Abstract][Full Text] [Related]
4. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism.
Momotani N; Noh JY; Ishikawa N; Ito K
J Clin Endocrinol Metab; 1997 Nov; 82(11):3633-6. PubMed ID: 9360518
[TBL] [Abstract][Full Text] [Related]
5. Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation.
Yoshihara A; Noh J; Yamaguchi T; Ohye H; Sato S; Sekiya K; Kosuga Y; Suzuki M; Matsumoto M; Kunii Y; Watanabe N; Mukasa K; Ito K; Ito K
J Clin Endocrinol Metab; 2012 Jul; 97(7):2396-403. PubMed ID: 22547422
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil.
Sato H; Hattori M; Fujieda M; Sugihara S; Inomata H; Hoshi M; Miyamoto S
J Clin Endocrinol Metab; 2000 Nov; 85(11):4270-3. PubMed ID: 11095466
[TBL] [Abstract][Full Text] [Related]
7. The Differential Effects of Propylthiouracil and Methimazole as Graves' Disease Treatment on Vascular Atherosclerosis Markers: A Randomized Clinical Trial.
Wisnu W; Alwi I; Nafrialdi N; Harimurti K; Pemayun TGD; Jusman SWA; Santoso DIS; Harahap AR; Suwarto S; Subekti I
Front Endocrinol (Lausanne); 2021; 12():796194. PubMed ID: 34987480
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves' disease treated with propylthiouracil or methimazole in Taiwan.
Huang CN; Hsu TC; Chou HH; Tsay GJ
J Formos Med Assoc; 2004 Apr; 103(4):274-9. PubMed ID: 15175822
[TBL] [Abstract][Full Text] [Related]
9. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
[TBL] [Abstract][Full Text] [Related]
10. [Antithyroid drugs therapy].
Fumarola A; Calvanese A; Di Fiore A; Dainelli M; D'Armiento M
Clin Ter; 2009; 160(1):47-53. PubMed ID: 19290412
[TBL] [Abstract][Full Text] [Related]
11. Reevaluation of the effects of methylmercaptoimidazole and propylthiouracil in patients with Graves' hyperthyroidism.
Okamura K; Ikenoue H; Shiroozu A; Sato K; Yoshinari M; Fujishima M
J Clin Endocrinol Metab; 1987 Oct; 65(4):719-23. PubMed ID: 3654917
[TBL] [Abstract][Full Text] [Related]
12. Malformations following methimazole exposure in utero: an open issue.
Ferraris S; Valenzise M; Lerone M; Divizia MT; Rosaia L; Blaid D; Nemelka O; Ferrero GB; Silengo M
Birth Defects Res A Clin Mol Teratol; 2003 Dec; 67(12):989-92. PubMed ID: 14745920
[TBL] [Abstract][Full Text] [Related]
13. Comparison of antithyroid drugs efficacy on P wave changes in patients with Graves' disease.
Berker D; Işik S; Canbay A; Aydin Y; Tütüncü Y; Delibaşi T; Güler S
Anadolu Kardiyol Derg; 2009 Aug; 9(4):298-303. PubMed ID: 19666432
[TBL] [Abstract][Full Text] [Related]
14. Influence of propylthiouracil and methimazole pre-treatment on the outcome of iodine-131 therapy in hyperthyroid patients with Graves' disease.
Shi GM; Xu Q; Zhu CY; Yang YL
J Int Med Res; 2009; 37(2):576-82. PubMed ID: 19383254
[TBL] [Abstract][Full Text] [Related]
15. [Therapy of hypo- and hyperthyroidism in pregnancy].
Lind P
Acta Med Austriaca; 1997; 24(4):157-8. PubMed ID: 9441554
[TBL] [Abstract][Full Text] [Related]
16. Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease.
Poomthavorn P; Mahachoklertwattana P; Tapaneya-Olarn W; Chuansumrit A; Chunharas A
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1295-301. PubMed ID: 12549809
[TBL] [Abstract][Full Text] [Related]
17. [Current problems in the treatment of Graves' disease in pregnancy and in lactation].
Momotani N
Nihon Rinsho; 2006 Dec; 64(12):2297-302. PubMed ID: 17154095
[TBL] [Abstract][Full Text] [Related]
18. The propylthiouracil dilemma.
Glinoer D; Cooper DS
Curr Opin Endocrinol Diabetes Obes; 2012 Oct; 19(5):402-7. PubMed ID: 22820213
[TBL] [Abstract][Full Text] [Related]
19. Successful Re-administration of Low-dose of Methimazole (MMI) in Graves' Disease Patients Who Experienced Allergic Cutaneous Reactions to MMI at Initial Treatment and Had Received Long-term Propylthiouracil (PTU).
Kubota S
Intern Med; 2016; 55(22):3235-3237. PubMed ID: 27853063
[TBL] [Abstract][Full Text] [Related]
20. Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan.
Yoshihara A; Noh JY; Watanabe N; Mukasa K; Ohye H; Suzuki M; Matsumoto M; Kunii Y; Suzuki N; Kameda T; Iwaku K; Kobayashi S; Sugino K; Ito K
Thyroid; 2015 Oct; 25(10):1155-61. PubMed ID: 26222916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]